We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effects of a single injection of teriparatide on bone turnover markers in postmenopausal women.
- Authors
Shiraki, M.; Sugimoto, T.; Nakamura, T.
- Abstract
Summary: This study investigated the effects of a single administration of teriparatide on bone turnover markers in postmenopausal women. Teriparatide caused a transient increase in bone resorption and inhibition of bone formation followed by a subsequent increase in bone formation and a decrease in resorption that lasted at least 1 week. Introduction: This study aims to investigate the effects of a single subcutaneous administration of teriparatide on bone turnover markers to elucidate why once weekly intermittent administration of teriparatide is effective on osteoporosis. Methods: Pharmacokinetics and calcium metabolism and bone turnover parameters were measured in 30 postmenopausal women after two doses of teriparatide (28.2 or 56.5 μg injection) or placebo in a randomized, double-blind, placebo-controlled study. Results: Teriparatide plasma concentration increased in a dose-dependent manner, and the maximum concentration was achieved 1 h after injection. Serum levels of calcium and phosphorus were transiently increased and decreased after teriparatide injection, respectively. Calcium metabolism returned to baseline levels 24 h later. Two days after injection, the serum level of 1,25-dihydroxy vitamin D was increased by ~80 % from baseline for both doses of teriparatide. Serum levels of osteocalcin and procollagen type I N-terminal propeptide decreased during the first 24 h followed by a ~10 % increase for 14 days. The serum level of cross-linked N-telopeptide (NTX) of type I collagen increased during the first 24 h followed by a 10 to 12 % dose-dependent suppression from baseline for 14 days. Urinary cross-linked C-telopeptide of type I collagen changes occurred in the same direction as serum NTX, but not dose dependently. Conclusion: A single administration of teriparatide caused an immediate, transient increase in bone resorption and inhibited bone formation followed by an increase in bone formation and decrease in resorption for ≥1 week. These findings may provide proof for the effect of a once-weekly regimen of teriparatide on bone turnover.
- Subjects
JAPAN; CALCIUM metabolism; OSTEOPOROSIS prevention; BIOMARKERS; BLOOD testing; HEALTH outcome assessment; PARATHYROID hormone; PLACEBOS; RESEARCH funding; URINE; EQUIPMENT &; supplies; RANDOMIZED controlled trials; TREATMENT effectiveness; BLIND experiment; POSTMENOPAUSE; DESCRIPTIVE statistics; THERAPEUTICS
- Publication
Osteoporosis International, 2013, Vol 24, Issue 1, p219
- ISSN
0937-941X
- Publication type
Article
- DOI
10.1007/s00198-012-2159-7